BRUSSELS, Sept. 18 (Xinhua) -- The European Commission on Friday concluded its second contract with a pharmaceutical company for a possible vaccine against COVID-19, the Commission said in a statement.
The contract signed with France's Sanofi and GlaxoSmithKline (GSK) of Britain will allow all European Union (EU) member states to purchase up to 300 million doses of the Sanofi-GSK vaccine. Moreover, member states may donate reserved doses to lower and middle-income countries.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
